Views & Analysis Towards patient centricity: Pfizer In a new series Amanda Barrell looks at how different companies are turning patient centricity into a reality.
Events Partner Content 2nd RNA Targeted Drug Discovery Summit At a time when the previously untapped drug discovery opportunity promised within RNA opens up, the
News Bayer aims at J&J and Pfizer with new prostate cancer drug The FDA has approved Bayer and Orion’s prostate cancer drug darolutamide in the early stages of the disease as it takes on rivals such as Johnson & Johnson.
News J&J adds rare disease wAIHA to Imaavy's potential uses Johnson & Johnson's 'Swiss army knife' drug Imaavy has shown efficacy in a pivotal trial involving patients with rare autoimmune disorder wAIHA.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
